Zydus Lifesciences Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
5,690.20
4,542.90
4,422.80
5,175.60
5,048.40
Other Income Qtr Cr156.4037.7054.0036.0037.80
Operating Revenues Qtr5,533.804,505.204,368.805,139.605,010.60

*All values are in Cr.

Operating Expenses Qtr
3,903.30
3,402.80
3,222.70
3,634.30
3,755.00
Operating Profit Qtr
1,630.50
1,102.40
1,146.10
1,505.30
1,255.60
EBIDT Qtr Cr
1,790.10
1,161.90
1,199.10
1,526.10
689.90
Depreciation Qtr
205.30
194.80
184.20
179.80
178.60
Net Profit Qtr
1,246.10
789.60
800.70
1,086.90
296.60
Basic EPS Qtr
11.69
7.80
7.91
10.74
2.93
Open Demat Account
or Resume your Application
+91 -

personImage